The global Traumatic Brain Injury Therapeutics Market is estimated to be valued at US$ 3.03 Bn or Mn in 2023 and is expected to exhibit a CAGR of 8.4% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.
Market Overview:
Traumatic brain injury therapeutics are used for the treatment of traumatic brain injury with products such as medications and devices. Traumatic brain injury occurs due to severe blow or jolt to the head that disrupts the normal brain functioning.
Market key trends:
One of the major trends contributing to the growth of traumatic brain injury therapeutics market is the increasing adoption of artificial intelligence (AI) based technologies. AI have the potential to improve the outcome of patients with traumatic brain injury by enabling accurate diagnosis and treatment. For instance, AI algorithms can analyze medical images such as CT scans and MRIs to accurately diagnose the severity and extent of brain injury. AI is also being utilized in developing personalized treatment plans for patients based on their individual injury characteristics and prognosis. This is expected to significantly drive the market growth during the forecast period.
Segment Analysis:
Content: The traumatic brain injury therapeutics market can be segmented based on type of injury, product type, end user and region. Based on type of injury, the market is segmented into focal TBI, diffuse TBI and other types of TBI. The diffuse TBI segment currently dominates the market as it accounts for approximately 70% of all TBIs. Diffuse TBI involves widespread damage across the brain rather than localized damage and tends to cause more severe cognitive and physical impairments.
Key Takeaways:
The Global Traumatic Brain Injury Therapeutics Market Demand is expected to witness high growth, exhibiting a CAGR of 8.4% over the forecast period, due to increasing incidence of road accidents and sports-related head injuries. North America is expected to be the fastest growing as well as the dominant region in the traumatic brain injury therapeutics market over the forecast period due to high awareness regarding head injuries, availability of advanced treatments and rising healthcare spending.
Regional analysis: North America accounts for the largest share of the global market currently and is expected to maintain its dominant position over the forecast period. This is attributed to factors such as high incidence of brain injuries, availability of advanced healthcare facilities and presence of major market players in the region.
Key players: Key players operating in the traumatic brain injury therapeutics market are AbbVie, Lundbeck, Eisai, Pfizer, Merck & Co., Inc., Novartis, AstraZeneca, GlaxoSmithKline, Acorda Therapeutics, and Ceretec.
Explorer more information on this topic, Please visit -
Falls and car accidents are two of the top reasons for traumatic brain injuries.
You can find ways to bring down your danger of mishaps that cause TBIs.
For better treatment opt for Head Injury Treatment Chennai.Who might get a traumatic brain injury?Anybody can encounter a TBI, albeit almost 80% of them happen to guys.
Individuals in this age bunch are more inclined to losing their equilibrium, falling and hitting their heads.
Watch out for Headache & Migraine Clinic Chennai!However, even newborn children can encounter TBIs from episodes like tumbling from a bed or changing table, or all the more infrequently, from misuse.
Individuals associated with specific callings or exercises have a higher danger of TBIs, including:Athletes (both recreational and professional).Construction workers.Police and law enforcement.Military personnel’s.What are the major types of head injuries?HematomaHemorrhageConcussionEdemaSkull fractureDiffuse axonal injuryHow is a head injury diagnosed?One of the principal ways your PCP will evaluate your head injury is with the Glasgow Coma Scale (GCS).
